New York University School Of Medicine

CHICAGO — The issue of physician burnout has been increasingly recognized over the past decade, and it will persist until changes are made at the organizational level, according to speakers at the ACP Internal Medicine Meeting.

WEST PALM BEACH, Fla. — At-home use of online adaptive training paired with transcranial direct current stimulation improves cognition in MS patients, according to a presentation at ACTRIMS Forum.

Meeting the American Thoracic Society’s recommended air quality standard for long-term fine particulate matter exposure resulted in significant health benefits, researchers reported in the Annals of the American Thoracic Society.

Patients with lupus nephritis who receive voclosporin demonstrated “meaningful reductions” in proteinuria with no change in mean estimated glomerular filtration rate at 30 months, according to data presented at ACR Convergence 2021.

In this video, Stacy Loeb, MD, professor in the department of urology at NYU Grossman School of Medicine, discusses studies looking at genetic counseling and its effect on the management of advanced prostate cancer.

In this video, Stacy Loeb, MD, professor in the department of urology at NYU Grossman School of Medicine, discusses two studies about prostate cancer at the AUA Annual Meeting.

A collaborative team of cancer experts from leading academic institutions and organizations has released recommendations for optimal protection against COVID-19 among individuals with blood cancer.

Pharmacomechanical catheter-directed thrombolysis using an endovascular catheter was safe and effective in patients with pulmonary embolism, according to interim results of the RESCUE trial presented at VIVA 21.

Recreational ketamine use and availability have increased in the U.S. in recent years, despite still being an uncommon drug, according to study results published in American Journal of Public Health.

In patients with diabetes and chronic coronary disease, researchers found no incremental benefit employing routine invasive management compared with initial medical therapy, according to results from the ISCHEMIA trials.